# C3.ai, Inc. (AI)

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-12  
**Report type:** Primer (steps 1–3 of 19)  
**API endpoint:** GET /api/v1/research/AI/primer

## Business Model

---
source: coverage-next-full
ticker: AI
company: C3.ai, Inc.
step: 01
title: Business Model Overview
created: 2026-06-11
---

### Step 01 — Business Model Overview: C3.ai, Inc. (AI)

#### 1. Executive Summary

C3.ai is a pure-play enterprise AI platform company selling pre-built AI applications and a low-code/no-code AI development platform to large enterprises and government agencies. The company's defining characteristic is *extreme vertical specificity* — rather than selling horizontal AI tooling, it sells pre-built AI applications for oil-and-gas optimization, financial services compliance, defense/intelligence analytics, and manufacturing predictive maintenance. The business model has undergone a radical transformation over FY2023–FY2026: from a large-deal, direct-sales, alliance-dependent model toward a partner-led, consumption-based model with lower ACV but higher pipeline volume. [S1]

#### 2. Value-Chain Layer Map

```
Layer                        C3.ai's Position
─────────────────────────    ──────────────────────────────────────────
Infrastructure (GPU/IaaS)    NOT HERE — relies on Azure/AWS/GCP
Foundation Models (LLM)      NOT HERE — uses OpenAI, Anthropic, others
AI Dev Platform (MLOps)      ✓ C3 Agentic AI Platform (low-code AI builder)
Pre-Built AI Applications    ✓ C3 AI Applications (300+ apps, 8 verticals)
Generative AI Layer          ✓ C3 Generative AI (enterprise search, agents)
Systems Integration          Partial — Professional Services (16% revenue)
End Customer                 Large enterprises (Fortune 1000) + Federal/DoD
```

**Key insight:** C3.ai occupies the application and platform layers, deliberately avoiding the commodity infrastructure race. Its moat thesis rests on pre-built, production-ready AI apps with embedded domain expertise (e.g., oil & gas yield optimization, anti-money-laundering detection) that would take years to replicate in-house. [S1]

#### 3. Product Architecture

##### C3 Agentic AI Platform
Low-code/no-code environment for enterprises to build, deploy, and manage AI applications. Includes data integration, model management, workflow orchestration, and monitoring tools. Launched "Agentic" branding in FY2025–FY2026 to capitalize on the LLM/agent wave. [S2]

##### C3 AI Applications (300+ pre-built applications)
Domain-specific, production-ready AI applications across 8 verticals:
- **Energy:** Reliability, production optimization, energy management
- **Financial Services:** Fraud detection, AML, credit risk, CRM
- **Government / Defense / Intelligence:** Predictive maintenance, logistics optimization, threat detection
- **Manufacturing:** Predictive maintenance, quality, supply chain
- **Healthcare:** Patient engagement, chronic disease management
- **Telecommunications:** Network reliability, churn prediction
- **Retail/CPG:** Demand forecasting, inventory optimization
- **Utilities:** Grid reliability, energy efficiency

##### C3 Generative AI (Gen AI)
Enterprise generative AI applications launched in FY2023–FY2024. Includes enterprise search (retrieval-augmented generation over proprietary data), AI assistants, and multi-agent orchestration. Designed as a bridge between pre-built applications and more open-ended AI use cases. [S2]

#### 4. Revenue Architecture

##### Revenue Streams
| Stream | FY2025 Mix | Nature |
|--------|-----------|--------|
| Subscription | ~84% (~$291M) | Annual + multi-year SaaS contracts; ARR-based |
| Professional Services | ~16% (~$55M) | Implementation, customization, integration |
| **Total** | **100% (~$347M)** | Fiscal year ends April 30 |

**Business model shift:** Pre-FY2023, C3.ai derived ~$92M/year (30%+ of revenue) from the Baker Hughes joint venture — a near-captive, high-margin stream. As Baker Hughes wound down (fully by FY2024 at ~$16M), C3.ai had to replace this with organic commercial sales, exposing the true competitive challenges of its direct-sales model. [S3]

##### Go-to-Market Evolution
- **Pre-FY2023:** Large enterprise, direct-sales, enterprise license agreements (ELAs); few large deals; heavily dependent on Baker Hughes
- **FY2023–FY2025:** Transition to Individual Purchase Agreements (IPDs), consumption-based pricing, and partner-led model (Azure co-sell, AWS Marketplace, GCP Marketplace, McKinsey, PwC, Booz Allen Hamilton)
- **FY2025–FY2026 (Ehikian era):** "Agentic AI" re-pivot; emphasis on federal/national security contracts; Ehikian background in federal AI deployments at AWS Government

**FY2025 agreement count:** 174 total agreements (vs. 123 in FY2024 and 49 prior) — IPD model driving volume growth but lower ACV. [S2]

##### Customer Concentration Risk
Historically extreme (Baker Hughes ~30%+ of revenue through FY2022). Post-BH wind-down, remaining top-10 customers likely represent 40–50% of revenue (estimates; exact figures require FY2026 10-K). Federal/DoD customers include USAF, Army, DHS, DoE — increasing government revenue concentration as a replacement for BH dependency.

#### 5. Partner Ecosystem

| Partner | Role | Deal Contribution |
|---------|------|------------------|
| Microsoft Azure | Preferred cloud; co-sell; MSA ordering; 28 C3 deals | High |
| AWS Marketplace | Distribution; government ATO facilitation | Medium |
| Google Cloud Platform | Listed; integration with Vertex AI | Medium |
| McKinsey & Company | System integration + implementation | Medium |
| PwC | ERP-adjacent AI deployments | Medium |
| Booz Allen Hamilton | Federal/intelligence sector | High (growing) |
| Baker Hughes | Wind-down; historically ~$92M/year; now <$16M | Negligible |

Partner-driven bookings grew +419% in Q4 FY2024 per investor presentation data, suggesting the pivot is producing pipeline even if it has not yet stabilized revenue. [S4]

#### 6. Competitive Position Summary

C3.ai competes against:
1. **Hyperscalers (Azure AI, Google Vertex AI, AWS SageMaker):** Far more resources, bundled pricing advantage, but C3.ai claims pre-built apps reduce enterprise deployment time from years to months
2. **Palantir:** Most direct comparable — both sell enterprise AI to governments and large corporations. Palantir has $3–4B revenue vs. C3.ai's ~$250M, and is now profitable.
3. **Specialized AI vendors:** Salesforce Einstein, IBM watsonx, DataRobot — narrow focus, less platform breadth

**C3.ai's stated differentiation:** Production-ready apps, multi-cloud neutrality (runs on Azure/AWS/GCP equally), and the ability to integrate with existing enterprise data infrastructure without a "rip and replace." [S5]

#### 7. Management & Ownership

- **Stephen Ehikian (CEO, since September 2025):** Former AWS Government head; enterprise AI deployment background; brought in to execute the federal/DoD pivot
- **Tom Siebel (Executive Chairman/Founder):** 38 Form 4 transactions since 2021 — all sales; systematic liquidation via 10b5-1 plan; retains ~9.1M shares but reduced control
- **Dual-class structure:** Class B shares (50 votes/share) gave Siebel near-total voting control; post-transition, governance dynamics unclear without FY2026 proxy detail

#### 8. Source Index

| ID | Source | Detail |
|----|--------|--------|
| S1 | FY2024 10-K | Company history, BH wind-down, business model pivot narrative |
| S2 | FY2025 10-K | Product families, GTM, agreement count (174 FY2025) |
| S3 | FY2024 10-K related-party disclosures | Baker Hughes revenue $92M→$16M |
| S4 | Investor presentation 2024 | Partner-driven bookings +419%; Microsoft alliance; strategy pillars |
| S5 | Competitive landscape file | Competitor profiles; Palantir comparison |

## Financial Snapshot

---
source: coverage-next-full
ticker: AI
company: C3.ai, Inc.
step: 04
title: Financial Quality & Adversarial Sweep
created: 2026-06-11
---

### Step 04 — Financial Quality & Adversarial Sweep: C3.ai, Inc. (AI)

#### 1. Executive Summary

C3.ai's reported financials contain multiple flags warranting careful scrutiny: SBC exceeding revenue in FY2026, anomalous gross margin collapse, persistent GAAP losses despite a $700M+ cash cushion, and a history of customer concentration that inflated apparent growth metrics. The Adversarial Research Sweep below examines the most serious external allegations and accounting concerns. The core assessment: C3.ai's financial reporting appears technically compliant but paints an overly optimistic picture through non-GAAP exclusions of SBC. The real cash burn is obscured by interest income on the cash hoard. [S1]

#### 2. Statement Quality Adjustments

##### Income Statement Adjustments

| Item | Reported (FY2025) | Adjustment | Adjusted |
|------|------------------|-----------|---------|
| Operating Loss | (~$152M) | — | (~$152M) |
| Add back: SBC (non-cash) | $231M | -$231M SBC excluded | N/A (SBC is real cost) |
| Interest income | ~$60M | Remove — not operating | (~$212M) adjusted operating loss |
| **True operating cash burn** | — | — | **~($62M) FCF** (per 10-K) |

**Key insight:** GAAP operating loss of ~$152M looks severe, but FCF burn of only ~$47M (FY2025) shows the difference between GAAP (which expensing SBC in full) and cash reality. However, SBC is economically real — it dilutes shareholders. On a cash-adjusted, SBC-included (diluted) basis, the company burns ~$150M+/year economically.

**Non-GAAP vs. GAAP:** C3.ai reports non-GAAP operating metrics that exclude SBC. Management highlighted "non-GAAP operating loss" improving materially (from ~($90M) non-GAAP to closer to breakeven). This is technically accurate but excludes the company's single largest expense category. [S1]

##### Revenue Quality Assessment

| Concern | Evidence | Severity |
|---------|----------|---------|
| Baker Hughes concentration | BH was ~30%+ of revenue through FY2022; created artificial growth profile | High (historical) |
| IPD model ACV compression | 174 agreements vs. 49 prior = volume up 3.5x but revenue flat/declining = ACV -75%? | High |
| Channel stuffing risk | Rapid agreement volume growth with revenue declining — are deals real? | Medium (monitor) |
| Deferred revenue build | Not prominently flagged; subscription model should show deferred revenue growth | Low-Medium |
| Professional services low-margin | 16% mix at ~15% gross margin; if this grows, blended margin deteriorates | Medium |

#### 3. Balance Sheet Quality

##### Cash Position
| Date | Cash + Mkt Securities | Net Cash (vs. $0 debt) |
|------|----------------------|----------------------|
| FY2024 (Apr 2024) | ~$770M | ~$770M |
| FY2025 (Apr 2025) | ~$742M | ~$742M |
| Q4 FY2026 (Apr 2026, est.) | ~$673M | ~$673M |

Cash declined ~$70M over FY2025 (burn ≈ FCF burn of $47M + other) and another ~$69M over FY2026 YTD (Q3 FY2026 implied). The cash runway is substantial (>5 years at current burn rate), but the direction is negative.

##### Receivables / DSO
DSO estimation from XBRL not fully available, but professional services contracts and federal contracts can have extended payment terms (60–90+ days). Worth monitoring for FY2026 10-K.

##### Intangibles / Goodwill
C3.ai has minimal goodwill from acquisitions — the company has grown organically. No major goodwill impairment risk.

##### Operating Leases
Long-term operating leases (~$34M remaining per FY2025 10-K) for office space. No financial debt. Clean balance sheet from a leverage perspective.

#### 4. Adversarial Research Sweep

*Methodology: Web search for short seller reports, SEC investigations, class action lawsuits, whistleblower allegations, regulatory enforcement actions, and major accounting controversies related to C3.ai. No earnings transcripts loaded — relies on public filings, press coverage, and regulatory databases.*

---

##### Finding 1: Short Seller Reports (Multiple, 2021–2023)
**Source:** Multiple short-selling research publications; widely covered in financial press [S3]
**Allegation:** In 2021–2022, short sellers (including alleged Spruce Point Capital research coverage) questioned C3.ai's revenue recognition practices, particularly around the Baker Hughes alliance — alleging that the revenue was essentially a "barter" arrangement where Siebel and Baker Hughes CEO Lorenzo Simonelli had interlocking incentives. The allegation was that reported BH revenue was artificially inflated and would collapse once the relationship normalized.
**Current status:** The collapse of BH revenue (from $92M to $16M by FY2024) largely validated the concern — it was a related-party distortion, not organic customer demand. C3.ai disclosed this as a related-party transaction and wound it down properly. No SEC enforcement action resulted.
**Severity:** RESOLVED (the distortion is now in the past). The bear case was right — BH revenue was not reproducible.

---

##### Finding 2: IPO Lock-Up / Insider Selling Pattern
**Source:** Form 4 filings via SEC EDGAR [S4]
**Allegation:** Not an allegation per se, but 38 Form 4 filings for Tom Siebel with zero purchases since 2021 — all sales. Systematic liquidation via 10b5-1 plan. Remaining ownership ~9.1M shares down from original post-IPO holdings.
**Interpretation:** While 10b5-1 plans can be set up in good faith, the consistent selling pattern with no purchases is a negative signal for long-term conviction from the founder. The CEO transition to Ehikian with Siebel remaining as Executive Chairman may be a succession pathway or may indicate Siebel's reduced commitment.
**Severity:** MEDIUM — ongoing overhang; not fraud, but negative governance signal.

---

##### Finding 3: Revenue Recognition and IPD Model Integrity
**Source:** FY2024 and FY2025 10-K risk factor disclosures [S1]
**Concern:** The shift to Individual Purchase Agreements (IPDs) — consumption-based contracts — creates revenue recognition timing variability. Unlike traditional SaaS ARR, consumption revenue can be lumpy. The dramatic Q3 FY2026 revenue step-down (-44% YoY, -29% sequentially) could indicate:
1. CEO transition disrupting sales organization (legitimate operational issue)
2. IPD contracts not renewing / customers consuming less than contracted
3. A federal contract timing gap (contracts delayed by CR/budget uncertainty)
4. Channel conflict between partner-led and direct sales during transition
**Evidence for/against fraud:** No SEC investigation; 10-K disclosures are detailed and disclose all material customer concentration. Audit firm (KPMG) has not flagged material weaknesses.
**Severity:** MEDIUM-HIGH — not fraud, but the Q3 FY2026 step-down needs management explanation (available in earnings call transcript, which is not loaded here).

---

##### Finding 4: Class Action Lawsuits
**Source:** Legal databases; press coverage [S3]
**Status:** C3.ai faced securities class action litigation in 2023 related to alleged misrepresentations about growth prospects and the Baker Hughes relationship. Settlement status as of research date unknown. Management disclosed the litigation in FY2024/FY2025 10-K risk factors.
**Financial impact:** Any settlement would be a one-time charge; no indication of material financial impact.
**Severity:** LOW-MEDIUM (ongoing legal risk, not existential).

---

##### Finding 5: SBC > Revenue (FY2026)
**Source:** StockAnalysis.com FY2026 data; SEC XBRL SBC trend [S2]
**Concern:** If FY2026 SBC is ~$264M on ~$250M revenue, this is economically unsustainable. Large new CEO grants to Ehikian + leadership refresh likely drove this spike. However:
- Grants to new executives are typically front-loaded and amortized over vesting schedules
- Future SBC should decline as grants vest (if no new major refresh occurs)
- The company will need to disclose SBC trajectory in the FY2026 10-K
**Severity:** HIGH (dilution risk) — but may be transient if driven by CEO onboarding grants.

---

#### 5. Audit Quality Assessment

- **Auditor:** KPMG LLP (Big 4)
- **Audit opinions:** Unqualified in FY2025 and FY2024 10-K
- **Material weaknesses:** None disclosed in recent filings
- **Related-party disclosures:** Adequately disclosed (Baker Hughes, board members)
- **Revenue recognition policy:** ASC 606 compliant; subscription and PS revenue recognized separately

Overall audit quality: **Satisfactory**. No red flags in audit opinions. The Baker Hughes related-party transaction was properly disclosed throughout.

#### 6. Cash Burn Analysis

| FY | Operating CF | CapEx | FCF | Cash Balance EOY |
|----|-------------|-------|-----|-----------------|
| FY2022 | ($94M) | ($20M) | ($114M) | — |
| FY2023 | ($79M) | ($22M) | ($101M) | — |
| FY2024 | ($68M) | ($25M) | ($90M) | ~$770M |
| FY2025 | ($44M) | ($3M) | ($47M) | ~$742M |
| FY2026 est. | ($60–80M est.) | — | (~$65M est.) | ~$673M |

**FCF improving trend (FY2022→FY2025):** From -$114M to -$47M — genuine improvement driven by operating leverage. However, FY2026 may reverse this as revenue declines faster than costs.

**Cash runway:** At $673M cash and ~$65M/year burn rate, C3.ai has ~10+ years of runway — not an existential concern.

#### 7. Source Index

| ID | Source | Detail |
|----|--------|--------|
| S1 | FY2025 10-K | P&L, risk factors, non-GAAP disclosures, audit opinion |
| S2 | StockAnalysis.com, XBRL SBC data | FY2026 SBC estimate; historical SBC trend |
| S3 | Press coverage, legal databases | Short seller reports, class action |
| S4 | SEC Form 4 filings | Insider transaction history (38 Form 4s) |
| S5 | FY2024 10-K | Baker Hughes related-party disclosure; litigation disclosures |

## Recent Catalysts

---
source: coverage-next-full
ticker: AI
company: C3.ai, Inc.
step: 12
title: Bull/Bear Catalysts (Analyst Debate)
created: 2026-06-11
note: Transcripts not loaded — analysis based on consensus notes, press releases, 10-K filings, and recent news
---

### Step 12 — Bull/Bear Catalysts: C3.ai, Inc. (AI)

#### 1. Executive Summary

C3.ai is one of the most debated stocks in enterprise AI. The bull and bear cases are both coherent and supported by real data — which is why the stock carries ~35% short interest (one of the highest in enterprise software) while simultaneously commanding a meaningful premium to net cash. The debate centers on three pivotal questions: (1) Is the FY2026 revenue collapse transient (CEO transition disruption) or structural (business model failure)? (2) Can federal/DoD contracts replace commercial revenue at scale? (3) Will SBC dilution permanently impair shareholder value? [S1]

*Note: No earnings call transcripts loaded. The analyst debate below is synthesized from consensus estimates, analyst ratings, press coverage, investor presentations, and 10-K filings.*

#### 2. Bull Case Analysis

##### Bull Argument 1: Net Cash Provides Hard Floor + Optionality
At $10.60/share with $4.77/share net cash, the operating business is valued at only ~$5.83/share (~2.1x EV/Revenue). If the business stabilizes at even $225M revenue with 50% gross margins, the EV is extraordinarily cheap vs. any optimistic scenario. The cash hoard (8+ year runway) eliminates the bankruptcy risk that would normally accompany this level of operational deterioration. Wedbush recently reiterated a Buy with a $24 target — implying the market is dramatically undervaluing the business at current prices. [S2]

##### Bull Argument 2: CEO Transition Disruption Is a One-Time Event
The Q3 FY2026 sequential revenue step-down (-29%) coincided precisely with Stephen Ehikian's September 2025 appointment. In enterprise software, CEO transitions universally cause temporary sales paralysis as the organization waits for strategic clarity, territories reset, and quotas are renegotiated. Historical precedent (Salesforce's transition period, Workday's early-growth CEO changes) shows that post-transition recovery often brings accelerated growth as the new leader instills operational discipline. Ehikian's $210–240M FY2027 guide is the "kitchen sink" — conservative new-CEO guidance designed to under-promise and over-deliver.

##### Bull Argument 3: Federal/DoD Is a Massive Underappreciated Opportunity
The U.S. DoD's AI budget is growing rapidly. Ehikian's background (AWS Government, federal AI deployments at scale) positions C3.ai uniquely. Federal contracts are lumpy — a single $50–100M DoD contract would represent a 20–45% revenue step-up. The Booz Allen Hamilton partnership provides deep federal penetration. FedRAMP authorizations and existing ATO certifications create genuine switching-cost moats with government customers. If even one large multi-year federal contract is announced, the stock would re-rate dramatically.

**Bull Case — 3 Bullets:**
1. **Net cash floor ($4.77/share) means EV/Revenue is ~2x on severely depressed revenue — priced for extinction, not recovery**
2. **CEO transition disruption explains Q3/Q4 FY2026 collapse; Ehikian's federal background and $210–240M guide is a classic kitchen-sink reset**
3. **Single large DoD/federal contract announcement could instantly re-rate the stock toward Palantir-like multiples (35x EV/Revenue)**

#### 3. Bear Case Analysis

##### Bear Argument 1: Revenue Decline Is Structural, Not Transient
The FY2026 guidance ($210–240M, -4% to -15% from FY2026's $250M) was issued by the *new* CEO who had 6+ months to assess the business. Ehikian is not guiding for a recovery — he is guiding for continued contraction. This is deeply unusual: a new CEO kitchen-sinking typically involves one "bad" year, not guidance for ongoing decline. Morgan Stanley (Price Target: $7), Citizens (downgraded), and 6 Sell-rated analysts reflect a view that C3.ai is in a structural decline. The IPD model is generating *agreements* but not *revenue* — ACV has fallen 90% from $11M (FY2022) to ~$1.1M (FY2026). [S3]

##### Bear Argument 2: SBC Exceeding Revenue Is Value-Destroying Perpetual Dilution
At ~$264M SBC on ~$250M revenue (FY2026), C3.ai is handing out more in equity than it earns in revenue. Even if the operating business were breakeven, the dilution would destroy shareholder value at ~16–18% per year. New CEO equity grants will vest over 4 years, meaning this burden continues. The company's response — citing "non-GAAP" metrics that exclude SBC — is the textbook definition of obscuring real economic costs. Short sellers highlight this as the central structural issue.

##### Bear Argument 3: Hyperscalers Are Winning the Enterprise AI Platform War
Microsoft, Google, and Amazon are investing hundreds of billions in AI infrastructure and adding pre-built AI application catalogs at near-zero marginal cost to existing cloud customers. In a world where Azure AI Studio, Google Vertex AI, and AWS Bedrock can do "80% of what C3.ai does" as part of a company's existing cloud contract, C3.ai's pricing power evaporates. The 35% short interest reflects the market's view that this is an existential competitive threat, not a speed bump.

**Bear Case — 3 Bullets:**
1. **FY2027 guidance from the new CEO himself shows further revenue decline — not a recovery story but a managed deterioration**
2. **SBC >100% of revenue is diluting shareholders faster than the operating business creates value; GAAP EPS is worsening**
3. **Hyperscalers are commoditizing the enterprise AI platform layer; C3.ai is caught in a structural squeeze between hyperscaler bundling and specialized point solutions**

#### 4. Analyst Sentiment Snapshot

| Firm | Rating | PT | Stance |
|------|--------|----|--------|
| Wedbush | Buy | $24 | "Dramatically undervalued vs. AI opportunity" |
| Canaccord | Hold | $10 | "Needs proof of federal execution" |
| UBS | Neutral | $12 | "Valuation fair on EV/Revenue; watch margins" |
| Morgan Stanley | Underweight | $7 | "Structurally challenged; execution risk high" |
| JMP Securities | Market Outperform | $24 | Optimistic federal pipeline |
| Citizens | Sell/Downgraded | — | Structural concerns |

**Consensus:** 2 Buy / 6 Hold / 6 Sell. Skewed bearish. Mean PT ~$10–11 (≈ current price).

#### 5. Thesis Inflection Points (Next 12 Months)

| Event | Bull Impact | Bear Impact |
|-------|------------|------------|
| Q1 FY2027 revenue (report ~Aug 2026) | Revenue above $225M YoY stop = bullish | Below $50M quarterly = further decline |
| Large federal contract announcement | Major re-rating event | N/A |
| FY2026 10-K filing (gross margin detail) | Normal GM (>50%) = restores confidence | Structural 25–30% GM = permanent damage |
| SBC guidance for FY2027 | Declining SBC = bullish | Sustained >80% SBC/Rev = structural problem |
| Buyback announcement | Highly bullish (56% of MC is cash) | No buyback = management prioritizes other use |
| CEO Ehikian investor day | Strategic clarity = bullish | No investor day / weak strategy = bearish |

#### 6. Source Index

| ID | Source | Detail |
|----|--------|--------|
| S1 | Consensus.md | Analyst ratings, short interest (~35% float), price targets |
| S2 | Consensus.md; Wedbush, JMP | Bull case $24 targets |
| S3 | Morgan Stanley, Citizens rating; FY2027 guidance | Bear case; guidance analysis |
| S4 | FY2025 10-K; investor presentation | Federal strategy; Ehikian background |

## Full Research Available

This primer covers steps 1–3 of 19. The full deep dive (moat analysis, DCF, bull/bear,
management quality, earnings transcript analysis) is available via:

- Investment memo: /memo/ai
- Full research API: GET /api/v1/research/AI/memo
- Coverage universe: /stocks